ArticleJournal of Crohn's & colitis2026
The introduction of an intestinal ultrasound service is associated with significantly reduced endoscopy usage in an inflammatory bowel disease service-the SCOPELESS study.
Article in Journal of Crohn's & colitis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologists.Therapeutic advances in gastroenterology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEndoscopy has been the gold standard for the assessment of inflammatory bowel disease (IBD) activity. Increasingly, intestinal ultrasound (IUS) is utilized as an alternative non-invasive disease monitoring strategy. The aim of this study was to quantify and compare endoscopy usage for evaluation of IBD disease activity before and after the introduction of an IUS service.
methodsA retrospective single-center study was performed. Total numbers of lower gastrointestinal endoscopies performed for assessment of disease activity in luminal Crohn's disease or ulcerative colitis were collected across two 5-year time periods: the pre-IUS era (2010-14) and the IUS era (2015-19). Endoscopies for dysplasia surveillance were excluded. The primary outcome was a comparison between the pre-IUS and IUS eras of the number of endoscopies performed for IBD activity assessment annually relative to the number of annual patients reviewed.
resultsThe number of endoscopies performed for IBD activity assessment decreased from 576 in the pre-IUS era to 474 in the IUS era despite an increase in cumulative annual patients (1746 vs 3080 patients in the pre-IUS and IUS eras, respectively). The proportion of cumulative annual endoscopies relative to cumulative patients reduced from 33 per 100 patients (pre-IUS era) to 15 per 100 patients (IUS-era) (incidence rate ratio 0.47, 95% CI 0.41-0.53; P < .001), a reduction of 53%. DISCUSSION: Following the introduction of an IUS service, the number of endoscopies performed for evaluation of IBD activity was halved. The potential workflow and cost savings of this reduction in endoscopy utilization may be significant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.